Abstract
The present study was conducted to develop and evaluate an experimental ISCOM-based infectious bursal disease (IBD) vaccine. The indigenous very virulent infectious bursal disease virus (vvIBDV) already attenuated and adapted to Vero cell line was used. After denaturation of viral proteins with sodium dodecyl sulphate (SDS), an IBD-ISCOM was constructed. The non-incorporated viral components were separated from ISCOM by centrifugation of dialysate. The pathogenicity and immunogenicity trials were conducted in 3-week-old broiler chicken. A commercial oil-emulsified vaccine (CEVAC IBD K) was used for comparison. There were no clinical signs of disease, gross or microscopic lesions in bursa of Fabricius in group G1 vaccinated with ISCOM-based vaccine and bursa to body weight ratio were comparable to un-vaccinated control group (G3). The virus-neutralizing antibody titers were significantly (P<0.05) higher in group G1 as compared with group G2 which was vaccinated with commercial vaccine. On challenge with vvIBDV, 100%, 75% and 0.00% protection was achieved in G1, G2 and G3, respectively. The results indicated that ISCOM-based IBD vaccine is safe and immunogenic.
Keywords: Infectious bursal disease, ISCOM, Vaccine
Full Text
The Full Text of this article is available as a PDF (456.8 KB).
References
- 1.Cosgrove A.S.An apparently new disease of chickenavian nephritis Avian Dis 19626385–389.10.2307/1587909 [Google Scholar]
- 2.Berg T.P. Acute infectious bursal disease in poultry: a review. Avian Pathol. 2000;29:175–190. doi: 10.1080/03079450050045431. [DOI] [PubMed] [Google Scholar]
- 3.Lukert PD and Saif YM (2003) Infectious bursal disease. In: Diseases of poultry (Saif YM eds). Ames Iowa State University Press. pp 161–179
- 4.Bhatti B.M. Incidence of poultry diseases and their importance in poultry production in Pakistan. Pak Vet J. 1989;9:194–197. [Google Scholar]
- 5.Akhtar S., Zahid S., Hussain A. Relative susceptibility of six broiler chicken strains to infectious bursal disease (Gumboro) during an epidemic. Pak Vet J. 1992;12:18–20. [Google Scholar]
- 6.Farooq M., Durrani F.R., Faisal S., Asghar A., Khurshid A. Incidence of infectious bursal disease among birds submitted to a diagnostic laboratory in NWFP, Pakistan. Pak Vet J. 2000;20:77–80. [Google Scholar]
- 7.Zahoor M.A., Hussain I., Khan Q.M. Two outbreaks of vvIBDV in Pakistan. Vet Rec. 2005;157:813. doi: 10.1136/vr.157.25.813. [DOI] [PubMed] [Google Scholar]
- 8.Rasool M.H., Hussain I. Preparation and evaluation of Vero-cell infectious bursal disease vaccine in Pakistan. Vaccine. 2006;24:2810–2814. doi: 10.1016/j.vaccine.2006.01.044. [DOI] [PubMed] [Google Scholar]
- 9.Morein B., Sundquist B., Hoglund S., Dalsgaard K., Osterhaus A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature. 1984;308:457–460. doi: 10.1038/308457a0. [DOI] [PubMed] [Google Scholar]
- 10.Sjolander A., Cox J.C., Barr I.G. ISCOMs: an adjuvant with multiple functions. J Leukocyte Biol. 1998;64:713–723. doi: 10.1002/jlb.64.6.713. [DOI] [PubMed] [Google Scholar]
- 11.Barr I., Mitchell G.F. ISCOMs (immunostimulating complexes): The first decade. Immunol Cell Biol. 1996;74:8–25. doi: 10.1038/icb.1996.2. [DOI] [PubMed] [Google Scholar]
- 12.Claassen I., Osterhaus A. The iscome structure as an immune enhancing moiety: experience with viral system. Res Immumol. 1992;143:531–541. doi: 10.1016/0923-2494(92)80065-s. [DOI] [PubMed] [Google Scholar]
- 13.Kersten G.F.A., Teearlink T., Derks H.J. Incorporation of the major outer membrane proteins of Neisseria gonorrhoea in saponins-lipid complexes (ISCOMs): Chemical analysis, some structural features and comparison of their immunogenicity with three other antigen delivery system. Infect Immunol. 1988;56:432–438. doi: 10.1128/iai.56.2.432-438.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Deliyannis G., Juckson D.C., Dyer W., Bates J., Coultr A., Harling L.M., Brown L.E. Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use. Vaccine. 1998;16:2058–2068. doi: 10.1016/s0264-410x(98)00080-2. [DOI] [PubMed] [Google Scholar]
- 15.Morein B., Hu K.F., Abusugra I. Current status and potential application of ISCOMs in veterinary medicine. Adv Drug Deliv Rev. 2004;56:1367–1382. doi: 10.1016/j.addr.2004.02.004. [DOI] [PubMed] [Google Scholar]
- 16.Chavez I.R.R., Rosenberger J.K., Cloud S.S., Pope C.R. Characterization of the antigenic, immunogenic and pathogenic variation of infectious bursal disease due to propagation in different host systems (bursa, embryo, and cell culture). II. Antigenicity at the epitope level. Avian Pathol. 2002;31:473–483. doi: 10.1080/0307945021000005842. [DOI] [PubMed] [Google Scholar]
- 17.Abdel-Alim G.A., Saif Y.M.Pathogenicity of cell culture derived and bursa derived infectious bursal disease viruses in specific-pathogen-free chicken Avian Dis 200145844–852.10.2307/1592864 [PubMed] [Google Scholar]
- 18.Rosenberger JK, Saif YM and Jackwood DJ (1998) Infectious bursal disease. In: isolation and identification of avian pathogens. Am Assoc of Avian Pathol. p.215–218
- 19.Skeeles J.K., Lukert P.D., Fletcher O.J., Leonard D.J.Immunization studies with a cell culture adapted infectious bursal disease virus Avian Dis 197923456–465.10.2307/1589576 [Google Scholar]
- 20.Hassan M.K., Natour M.Q., Ward L.A., Saif Y.M.Pathogenicity, attenuation and immunogenicity of infectious bursal disease virus Avian Dis 199640567–571.10.2307/1592265 [PubMed] [Google Scholar]